LIBTAYO is approved for people with a type of lung cancer called non–small cell lung cancer (NSCLC). LIBTAYO may be used as your first treatment when your lung cancer has not spread outside your chest (locally advanced lung cancer) and you cannot have surgery or chemotherapy with radiation, or your lung cancer has spread to other areas of your body (metastatic lung cancer), and your tumor tests positive for high “PD-L1,” and your tumor does not have an abnormal “EGFR,” “ALK,” or “ROS1” gene
LIBTAYO is approved for people with a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced BCC) and who have received treatment with a hedgehog inhibitor (HHI), or cannot receive treatment with an HHI
The first treatment approved for people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation
Add the LIBTAYO Surround contact number to your mobile phone, so you don’t miss our call if you sign up!
LIBTAYO Surround: 1.877.LIBTAYO (1.877.542.8296)
Tap here to download the LIBTAYO Surround contact number, so you don’t miss our call if you sign up!